4D Molecular Therapeutics, Inc. (FDMT) has a market capitalization of $493.16M and trades at $9.66. The 52-week range is 2.235-12.34.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4, Earnings Per Share (EPS) of $-2.42, annual revenue of $85.21M.
The stock has a beta of 2.93, operates in the Healthcare sector.
